Pa ge 1 Pa ge 1 American Journal of Life Science and Innovation (AJLSI) Difference of Clinical Parameters and Correlation between Type-1 and Type-2 Diabetes Mellitus (DM) Subjects in Bangladesh Khaleda Ferdous1, Md. Ashiqur Rahman2*, Sadia Islam3, Sadia Tasnim1, Saraf Tasnim1, Shohanur Rahaman4 Md. Raihanul Islam2, Md. Biplob Hossain4 Volume 2 Issue 3, Year 2023 ISSN: 2833-1397 (Online) DOI: https://doi.org/10.54536/ajlsi.v2i3.1928 https://journals.e-palli.com/home/index.php/ajlsi Article Information ABSTRACT Received: August 09, 2023 Accepted: August 31, 2023 Published: September 15, 2023 Type I and Type 2 diabetes are the two main types with types diabetes accounting for the majority (>85%) of total diabetes prevalence. Both forms of diabetes can lead to multisystem complications of microvascular endpoints including retinopathy, nephropathy and neuropathy and microvascular endpoints including is cadmic heart disease, stroke and peripheral vascular disease. The premature morbidity, mortality, reduced life expectancy and financial and other others costs of diabetes make if an important public health condition. The aim of this study was to observe the clinical condition and consequences patients with diabetes mellitus in Bangladesh. A descriptive cross-sectional study was conducted for the study. Data are collected from BIHS General Hospital. The results showed that, among 100 patients 20% patient was affected by Type-1 Diabetes Mellitus (DM) and 80% patient was affected by Type-2 Diabetes Mellitus (DM). In comparison between Type-1 and Type-2 DM patient’s result showing that Fasting Plasma Glucose (FPG) and 2 hour ABF plasma Glucose range is slightly high in Type-1 DM than Type-2 DM. On the other hand, Creatinine, HbA1C, TSH, Total cholesterol (TC), Triglycerides (TG), HDL ranges are increased in Type-2 DM patient. In this study males are affected 62% and females are 32%. So the ratio between male and female is 2:3. More patients were found in the age between 50-60 years and has risk among 40-50 years. Eating the right foods and adopting other life style behaviors that promotes healthy blood sugar and insulin levels will give you the best chance at avoiding diabetes. Keywords Type-1 DM, Type-2 DM, FPG, HbA1C, Lipid Profile INTRODUCTION Diabetes mellitus is a chronic disorder of glucose metabolism with serious clinical consequences. The multi system consequences of diabetes includes microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (ischemic heart disease, stroke, peripheral vascular disease) end points. The prevalence of diabetes has been rising in the last few decades. Diabetes is now a global problem. The premature morbidity, morality, reduced, life expectancy and financial and other costs to the patients with diabetes their careers and health service make it important public health condition. Diabetes affects persons of all ages and races (Afroz et al. 2019). The classification and diagnosis of diabetes are complex and have been the subjects of much consultation, debate and revision stretching over the past decades. The etiological classification of debates has now been widely accepted Type 1 and Type 2 diabetes are the 2 main types of diabetes and type 2 diabetes accounting for the majority (>85%) of total diabetes prevalence (Sato et al. 2009). Expert committees from the World Health Organization (WHO) and American Diabetes Association (ADA) have formulated, converged and diverged in their position on the diagnostic criteria for diabetes based on the measurement of fasting and 2h post load glucose but most recently there has been an ongoing debate on whether Glycated hemoglobin (HbA1C) should be used for diagnosing diabetes (WHO, 1999). Diabetes Mellitus (DM) is becoming a pandemic worldwide. WHO (World Health Organization) listed 10 countries to have the highest numbers of people with diabetes in 2000 and 2030. Bangladesh Appears in the list for both 2000 and 2030 with India, Pakistan, China, Japan, USA etc. According to a report, Bangladesh has 5.4 million of diabetic Subjects and the number is expected to increase to a staggering 11.1 million by 2030 (WHO, 1999). Several small-scale population-based studies conducted in Bangladesh at different time points have revealed an increasing trend of diabetes prevalence in rural and urban communities. A recent population bared study showed a significant increase in the prevalence of DM in rural Bangladesh from 2:3% to 6:8% over 5 years. This prevalence was higher than found in the previous rural studies of Bangladesh (Afroz et al. 2019). Diabetes mellitus is referred to a group of diseases characterized by high glucose levels in blood. It is caused by deficiency in the production or loss of function of insulin, which can occur because of different reasons resulting in protein and lipid metabolic disorders. The aim of this study is to systematically review diabetes mellitus and determine the variation of different parameters of the patients with type 1 and type 2 diabetes. The result will help to check the complications, injuries and other conditions in the patient. 1 Bangladesh University of Health Sciences (BUHS), Bangladesh 2 Novus Clinical Research Services Limited (NCRSL), Bangladesh 3 Bangladesh Specialized Hospital Limited (BSHL), Bangladesh 4 Diabetic Association of Bangladesh (BADAS) COVID-19 Diagnostic Laboratory, Bangladesh * Corresponding author’s e-mail: ararashiqur@gmail.com Pa ge 2 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 Epidemiology of Type-1 and Type-2 Diabetes Type-1 diabetes accounts for about 5% to 10% of all patients with diabetes. It is the most commonly diagnosed diabetes of youth (under 20 years of age) and causes ≥85% of all diabetes causes in this age group worldwide. It is estimated that 1106500 people aged 0-19 years have Type-1 diabetes worldwide with 132600 newly diagnosed cases each year. In USA, more than 17900 people aged under 20 years were newly diagnosed with Type-1 diabetes annually (annual rate for new cases about 21 in per 100000) (WHO, 1985). In a study of adults diagnosed with diabetes in the US in 2016 and 2017, type-1 diabetes accounted for 5.6 of cases. There is a significant geographic variation in the incidence of type-1 diabetes. It is more common in Europeans and less common in Asians. Thus, a child in Finland is 40 times more likely to develop Type-1 diabetes than a child in Japan and almost 100 times more likely to get the disease a child in the Zunyi region of China. Worldwide the incidence of type-1 diabetes is increasing by 3% every year although the reasons for this are unclear. One report showed a more rapid increase in nonwhite racial and ethnic group. Type-1 diabetes can present at any age with the highest incidence observed in children aged 10- 14 years (Sato et al. 2009). It affects males and females equally. In 30th March 2020, the result of meta-analysis showed that the incidence of type-1 diabetes was 15 per 10000 people and the prevalence was 9.5% (95% cl: 0.7 to 0.12) in the world, which was statistically significant. As a result, insulin will be difficult to access and afford, specially, in underdeveloped and developing countries (Magliano et al. 2015). Type-2 diabetes mellitus is one of the most common form of chronic disease globally. The rising burden of type-2 diabetes is now a major concern in health care worldwide. The global prevalence of diabetes mellitus is rapidly increasing as a result of population ageing, urbanization and associated lifestyle changes. The number of people with type-2 diabetes has more than doubled over the past 3 decades. In 2010, a research estimated 285 million people worldwide had type-2 diabetes mellitus and is projected to rise to 439 million by 2030 (Tharkar et al. 2010). The major burden of type-2 diabetes mellitus is now taking place in developing countries rather than in developed countries. 80% cases of type-2 diabetes mellitus worldwide live in less developed countries and areas. Asia has emerged as the “Diabetes Epidemic” in the worldwide as a result of rapid economic development, urbanization and nutrition transition over a relatively short period of time. Among the 10 countries with the largest numbers of people predicted to have diabetes mellitus in 2030. Amongst that 5 are in Asia. They are China, Pakistan, Indonesia and Bangladesh. In addition to Asia, the Gulf region in the Middle East and Africa are other hot spots for type-2 diabetes mellitus. A higher prevalence of type-2 diabetes mellitus in immigrants from the Middle East living in Sweden than in native Sweden has also been reported. The epidemic of type-2 diabetes mellitus is attributable to a mixture of genetic and epidemic predispositions and variety of behavioral and environmental risk factors (Kuzuya et al. 1997). Pathophysiology of Diabetes Mellitus Type-1 Diabetes Mellitus Type-1 diabetes mellitus results from the description of pancreatic B- cells that is mediated by the immune system. Multiple genetic and environmental factors in variable combinations in individual patients are involved in the development of type-1 diabetes mellitus. Generic risk is defined by the presence of particular allele combinations, which in the major susceptibility locus (the HLA region) affect T cell recognition and tolerance to foreign and autologous molecules (Alberti et al. 1998). Multiple other loci also regulate and affect features of specific immune responses and modify the vulnerability of B- cells to inflammatory mediators8. Compared with the genetic factors, environmental factors that affect the development of type-1 diabetes mellitus are less well characterized but contact with particular micro-organism is emerging as an important factor. Certain infections might affect immune regulation, and the role of commensal microorganisms such as gut microbiota, coxsackie, rubella viruses are important (Toumi et al. 1993). Some evidence also suggests that nutritional factors are important. Multiple islet specific autoantibodies are found in the circulation from a few weeks to up to 20 years before the onset if clinical disease and this prediabetes phase provides a potential opportunity to manipulate the islet- specific immune response to prevent or postpone B- cell loss. The latest developments in understanding the heterogeneity of type-1 diabetes mellitus and characterization of major disease type might help in the development of preventive treatments (Vionnet et al 1992). Diabetes symptoms varies depending on how much blood sugar level is devoted in patients. Some people may sometimes not experience symptoms. In type-1 diabetes mellitus, symptoms tend to come on quickly and can be serve it includes: Thirst, Increased Hunger (Specially after eating), Dry Mouth, Upset Stomach and Vomiting, Frequent Urination, Unexpected Weight Loss (Even though eating and feel hungry), Heavy, Labored Breathing (Doctor may call this kussmaul respiration), Crankiness or Mood Changes, Fatigue and Weakness, blurred vision, Shaking and Confusion, Bedwetting in Children who’s been Dry at Night (Murphy et al. 2008). Long term complications of diabetes develop gradually. The longer duration, the less controlled blood sugar, the higher risk of complications. Eventually diabetes complications may be disabling or life threatening. Heart and blood vessel disease (Cardiovascular disease), Never damage (Neuropathy), Kidney damage (Neuropathy), Eye damage, Foot damage, Skin and mouth infections, Pregnancy complications, Depression (Spyer et al. 2009). Type-2 Diabetes Mellitus Type-2 diabetes mellitus results from a defect in insulin Pa ge 3 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 secretion and an impairment of insulin action in hepatic and peripheral tissues, especially muscle tissue and adipocytes. A post receptor defect is also present causing resistance to the stimulatory effect of insulin deficiency develops, unlike the absolute deficiency founds in patients with type-1 diabetes mellitus (Stride et al. 2002). The specific etiologic factors are not known but genetic input is much stronger in type-2 diabetes mellitus than in the type-1 form. In a state of health, normal glycaemia is maintained by fine hormonal regulation of peripheral glucose uptake and hepatic production. Impaired glucose tolerance (IGT) is a transitional state from normal glycaemia to frank diabetes but patient with Impaired Glucose Tolerance (IGT) exhibit considerable heterogeneity. Type- 2 diabetes or glucose intolerance is part of a dysmetabolic syndrome (Syndrome X) that includes insulin resistance, hyperinsulinemia, obesity, hypertension and dyslipidemia (Davies et al. 2018). Current knowledge suggests that the development of glucose intolerance or diabetes is initiated by insulin resistance and worsened by the compensatory hyperinsulinemia. Insulin resistance is not only predictive for type-2 diabetes and associated with myriad metabolic derangements in fasting conditions but also non- diabetic insulin resistant individuals are subjected to a similar adverse postprandial metabolic setting are cardio metabolic risk as those with type-2 diabetes mellitus (Mitrofanova et al. 2019). In addition, the prevalence of hypertension rises with exacerbation of stages of impaired glucose metabolism. However, only in the early stages of impaired insulin metabolism do hyperglycemia and hyperinsulinemia appear to be significant contributors to the presence of hypertension (Welsh et al. 2010) Signs and symptoms of type-2 diabetes often develop slowly. In fact, anyone can be living with type-2 diabetes for years and not knowing it. It includes- Increased Thirst, Frequent Urination, Increased Hunger, Fatigue, Blurred Vision, Slow Healing Sores, Frequent Infections (Gums/ Skin/ Vaginal), Numbers or Tingling in the Hands or Feet, Areas of darkened skin, usually in the armpits and neck, Presence of Ketones in Urine. And complications such as Cardiovascular disease (Heart and Blood vessel disease), Nerve Damage (Neuropathy) in limbs, Kidney disease (Neuropathy), Eye damage, Skin infection, Foot damage, Hearing impairment, Slow healing, Sleep apnea, Dementia (Alzheimer’s Disease) (Mitrofanova et al. 2019). METHODOLOGY It was a cross-sectional study. It was a descriptive research that was mainly based on observation and data collection. The study conducted in Bangladesh Institute of Health Science (BIHS) and Bangladesh University of Health Sciences (BUHS). 100 Patients between the ages of 20 to 85 were approached to participate in the research. Sampling technique was purposive sampling. All data were collected in 26th December, 2020 to 4th March, 2021. Laboratory Tests In this study, some hematological and biochemical tests results were done to determine if there are any differences in the results between type-1 and type-2 diabetic patients. Normal values vary depending on age and type of diabetes. Different parameters measure the update health condition of a patient. In the laboratory, different amount of blood is needed for different kind of tests. The test was evaluated using a centrifuge which caused the contents of blood to separate anticoagulant was added to keep blood from clotting. Urine samples were also collected for tests. All tests were analyzed by an automated biochemistry analyzer machine for analysis Sample Collection A lab technologist had drawn blood from a vein, typically from the onside of patients elbow or from the back of hand. The technician cleaned the surface of the skin with an antiseptic and place an elastic or tourniquet around upper arm to help the vein swell with blood. Then inserted a needle in the vein and collect blood sample in one or more vials. The technologist removed the elastic band and cover the area with a bandage to stop the bleeding. Urine sample were collected in a vial. A container amount of urine was collected. Statistical Analysis Statistical analysis was done on an MS windows-based PC computer. The data were first keyed into a MS Excel spreadsheet and then analyzed by statistical package for the social sciences (SPSS). Inclusion Criteria Both men and women between 20 to 85 of age who are affected with type-1 and type-2 diabetes mellitus and are willing to participate voluntary and comply with the instruction of the study e.g. overnight fasting was considered eligible for the study. Exclusion Criteria People who are not qualified by inclusion criteria were excluded from study. Hey are given below- • Pregnant women. • Mentally disabled people. • Physically disabled people Figure 1: Distribution of Type-1 DM and Type-2 DM study subjects Pa ge 4 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 RESULTS Among 100 patients 20% patient was type-1 Diabetic patient and 80% patient was type-2 Diabetic patient. According to total sample pie chart are given below- In This study sample was taken among 20-85 years old patient. This graphical presentation represents that, Type- 1 diabetes mellitus is higher in younger peoples and Type- 2 diabetes mellitus is higher in older peoples. Among 100 patients 20% patient was type-1 Diabetic patient and 80% patient was type-2 Diabetic patient. Among those, Male patient is 62% and Female patient is 38%. This figure shows that male is more affected than female. In this study, Males are affected 62% and females are 38%. So, the ratio between male and female is 3:2. Figure shows that age group distribution of type-1 and type- 2 diabetes mellitus. Among 20-30 age group type-1 was 8 subjects and type-2 was 0 subjects. Accordingly, 30-40 age group type-1 was 10 subjects and type-2 was 7 subjects; Figure 2: Percentage of type-1 and type-2 DM Male and Female subjects Figure 3: Age group distribution chart of Type 1 and Type 2 DM study subjects Table 1: Mean value of different parameters among Type-1 and Type-2 diabetic subjects Variable Type-1 DM (n=20) Type-2 DM (n=80) Fasting Plasma Glucose 9.8 mmol/L 8.8 mmol/L 2 Hour ABF Plasma Glucose 11.2 mmol/L 10.2 mmol/L Creatinine 1.7 mg/dL 2.3 mg/dL HbA1c 6.7% 9.8% TSH 2.75 mIU/L 5.28 mIU/L Total Cholesterol (TC) 210 mg/dL 240 mg/dL Triglycerides (TG) 132 mg/dL 169 mg/dL HDL 42 mg/dL 65 mg/dL LDL 155 mg/dL 190 mg/dL Pa ge 5 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 Figure 4: Comparison of different glucose parameters between type-1 and type-2 diabetic subjects Figure 5: Comparison of creatinine & TSH parameters between type-1 and type-2 diabetic subjects Figure 6: Comparison of lipid profile between type-1 and type-2 diabetic subjects 40-50 age group type-1 was 2 subjects and type-2 was 18 subjects; 50-60 age group type-2 was 30 subjects; 60-70 age group type-2 was 13 subjects; 70-80 age group type-2 was 7 subjects and 80-90 age group type-2 was 5 subjects. Among 100 patients, 20% patients were Type-1 and 80% patients were Type-2 diabetic patients. In comparison between Type-1 and Type-2 diabetic patient showing that, Fasting plasma glucose is little bit higher in type-1 Pa ge 6 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 diabetic patient than type-2 diabetic patient. Creatinine range is lower in type-1 diabetic patient than in type-2 diabetic patient. HbA1c level is un type-2 diabetic patient than in type-1 diabetic patient. TSH level is significantly high in type-2 diabetic patient than in type-1 diabetic patient. Lipid profile is (TC, TG, HDL and LDL) high in type-2 diabetic patient than in type-1 diabetic patients. DISCUSSION Type-1 diabetes was previously called insulin dependent diabetes or juvenile onset diabetes. This is immune mediated diabetes. Type-1 diabetes mellitus results from an absolute deficiency of insulin due to autoimmune destruction of the insulin producing pancreatic beta cell (Khowaja et al. 2007). This type of diabetes can affect generally in early stage of life and insulin is required for survival. It has multiple genetic predispositions and has also been said to be related to environmental factors, though still poorly defined. This type of diabetes accounts for 5-10% of those with diabetes (Wang et al 2009). Type- 2 diabetes mellitus is the commonest form of diabetes. It is also called non-insulin dependent diabetes mellitus or adult-onset diabetes. This type of diabetes is characterized by insulin resistance or abnormal insulin secretion (Krop et al. 1998). Type-2 diabetes mellitus is a disorder entirely separate from type-1 diabetes mellitus. Relative beta cell insufficiency is by definition, present in all individuals with type-2 diabetes mellitus (Chaikledkaew et al. 2008). In most cases, this disorder is also characterized by insulin resistance detected at the level of skeletal muscle, adipose tissue and the liver. Insulin resistance at the former site results in decreased peripheral glucose disposal, while the latter in increased hepatic glucose production. In many individuals, the natural history of type-2 diabetes mellitus begins with a period of insulin resistance with preserved, indeed augmented pancreatic insulin secretion as the insensitivity to insulin action in peripheral tissues is overcome by hyper-insulinemia (Vanderlee et al. 2016). As a result, plasma glucose level remains relatively normal. As the disease progress, however pancreatic islet cell function falters and it is no longer able to meet the peripheral demand. As a result, insulin levels fail to keep up with requirement and hyperglycemia ensues. Type-2 diabetes mellitus accounts for approximately 90-95% of those with diabetes (Welsh et al. 2010). One study suggests that HbA1c has a relations with serum lipid profile, blood glucose level, serum creatinine and SGPT in diabetic patients (Roy et al. 2016). A significant correlation among HbA1c, FBG and PPG is in agreement with earlier reports. We also observed significant correlations between HbA1c and cholesterol, triglycerides, HDL and LDL in type 2 diabetic (Rosediani et al. 2006). Several investigators have reported significant correlations between HbA1c and lipid profiles and suggested the importance of glycemic control. It has also been reported that clinical significance of various lipid parameters including total cholesterol, triglycerides HDL and LDL in predisposing diabetic patients leads to cardiovascular complications (Islam et al. 2022). The study was done to estimate the different clinical parameter states in 100 Diabetes Mellitus (DM) patients in which 20 patients were Type-1 and 80 patients were Type-2 DM affected. Among them were 62% male and 38% female patients. Observation made in several categories. According to age distribution chart, it was found that younger people are more affected by type-1 DM and on the other side, older people are more affected by type-2 DM. Fasting plasma Glucose (FPG) and 2 Hour ABF Plasma Glucose level are higher in type-1 DM subjects than type-2 DM subjects. Creatinine range is lower in type-1 DM than type-2 DM patient. Similarly, HbA1C, TSH level and lipid profile is increased in type-2 DM patient than type-1 DM subjects. CONCLUSION In recent years, Diabetes Mellitus (DM) has appeared to be a global health problem. It is one of the leading causes of death, disability, and economic loss. Diabetes affects persons of all ages and races. This disease reduces both a person’s quality of life and life expectancy and imposes a large economic burden on the healthcare system and on families. REFERENCES Afroz, A., Alam, K., Ali, L., Karim, A., Alramadan, M. J., Habib, S. H., ... & Billah, B. (2019). Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of- illness study. BMC health services research, 19(1), 1-12 Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic medicine, 15(7), 539-553 Chaikledkaew, U., Pongchareonsuk, P., Chaiyakunapruk, N., & Ongphiphadhanakul, B. (2008). Factors affecting health‐care costs and hospitalizations among diabetic patients in Thai public hospitals. Value in health, 11, S69-S74 Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., ... & Buse, J. B. (2018). Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care, 41(12), 2669-2701 Islam, S., Hossen, M. A. A., Rahman, M. A., Lubaba, M. I., & Akram, A. (2022). Serum uric acid level among type-2 diabetes subjects attending in a tertiary hospital of Bangladesh. World Journal of Biology Pharmacy and Health Sciences, 12(1), 081-085. Khowaja, L. A., Khuwaja, A. K., & Cosgrove, P. (2007). Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC health services research, 7(1), 1-8 Krop, J. S., Powe, N. R., Weller, W. E., Shaffer, T. J., Saudek, C. D., & Anderson, G. F. (1998). Patterns of expenditures and use of services among older adults with diabetes: implications for the transition to Pa ge 7 https://journals.e-palli.com/home/index.php/ajlsi Am. J. Life Sci. Innov. 2(3) 1-7, 2023 capitated managed care. Diabetes care, 21(5), 747-752 Kuzuya T, Matsuda A. (1997). Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes care, 20(2), 219-220 Magliano, D. J., Zimmet, P., & Shaw, J. E. (2015). Classification of diabetes mellitus and other categories of glucose intolerance. International textbook of diabetes mellitus, 1-16 Mitrofanova, A., Sosa, M. A., & Fornoni, A. (2019). Lipid mediators of insulin signaling in diabetic kidney disease. American Journal of Physiology-Renal Physiology, 317(5), F1241-F1252 Murphy, R., Ellard, S., & Hattersley, A. T. (2008). Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nature clinical practice Endocrinology & metabolism, 4(4), 200-213 Rosediani, M., Azidah, A. K., & Mafauzy, M. (2006). Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. The Medical Journal of Malaysia, 61(1), 67-71 Roy, P. (2016). Clinical Significance of HbA1c in the Management of Complicated Type 2 Diabetic Patients in Bangladesh. Malaysian Journal of Medical and Biological Research, 3(2), 69-74 Sato, K. K., Hayashi, T., Harita, N., Yoneda, T., Nakamura, Y., Endo, G., & Kambe, H. (2009). Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care, 32(4), 644-646 Spyer, G., Macleod, K. M., Shepherd, M., Ellard, S., & Hattersley, A. T. (2009). Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabetic Medicine, 26(1), 14-18 Stride, A., Vaxillaire, M., Tuomi, T., Barbetti, F., Njølstad, P. R., Hansen, T., ... & Hattersley, A. T. (2002). The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia, 45, 427- 435. Tharkar, S., Devarajan, A., Kumpatla, S., & Viswanathan, V. (2010). The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes research and clinical practice, 89(3), 334-340 Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non—insulin- dependent onset of disease. Diabetes, 42(2), 359-362 Vanderlee, L., Ahmed, S., Ferdous, F., Farzana, F. D., Das, S. K., Ahmed, T., ... & Faruque, A. S. G. (2016). Self-care practices and barriers to compliance among patients with diabetes in a community in rural Bangladesh. International Journal of Diabetes in Developing Countries, 36, 320-326 Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., ... & Cohen, D. (1992). Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature, 356(6371), 721-722 Wang, W., McGreevey, W. P., Fu, C., Zhan, S., Luan, R., Chen, W., & Xu, B. (2009). Type 2 diabetes mellitus in China: a preventable economic burden. The American journal of managed care, 15(9), 593-601 Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., ... & Coward, R. J. (2010). Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell metabolism, 12(4), 329-340 World Health Organization. (1985). Diabetes Mellitus: Report of a WHO Study Group [meeting held in Geneva from 11 to 16 February 1985]. World Health Organization, (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999. Report No. WHO/NCD/NCS/99.2.